Johnson & Johnson to Resume European Union Vaccine Rollout
With the Johnson & Johnson vaccine paused in the United States, the European Union drug regulator found that the benefits outweigh the rare risk of blood clots.
Full Article
Johnson & Johnson to Resume European Union Vaccine Rollout
NYTimes.com
0 shares
1 views
You might like
Related news coverage
Greece: All adults can receive COVID-19 vaccines by end June
SeattlePI.com
ATHENS, Greece (AP) — Greece’s health minister says any adult who wants to be vaccinated against COVID-19 will be able to do so..
-
EU launches legal action against vaccine-maker AstraZeneca
SeattlePI.com
-
FTSE 100 little changed despite resurgence of aerospace-related stocks
Proactive Investors
-
US, Britain rush supplies to virus-stricken India
MENAFN.com
-
EU agency says people should get 2nd dose of AstraZeneca too
SeattlePI.com
Advertisement
More coverage
US health panel reviews J&J vaccine pause over rare clots
SeattlePI.com
With the U.S. pause of Johnson & Johnson’s COVID-19 vaccine stretched into a second week, authorities are weighing whether to..
-
EU agency to issue more guidance on AstraZeneca's COVID shot
SeattlePI.com
-
Norway lends AstraZeneca vaccine jabs to Sweden, Iceland
SeattlePI.com
-
EU preparing legal case against AstraZeneca over vaccine shortfalls: Sources
IndiaTimes
-
Johnson Johnson vaccine under investigation over deadly blood clot cases
NaturalNews.com